Peptides and therapeutic proteins--SRI conference. New opportunities for macromolecule development, delivery and commercialization. 17-18 November 2005, Philadelphia, PA, USA.
Craik
David
D
University of Queensland, Institute for Molecular Bioscience, Australian Research Council Special Research Center for Functional and Applied Genomics, Brisbane, Qld 4072, Australia. d.craik@imb.uq.edu.au
D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy; D016503:Drug Delivery Systems / Q000379:methods*; D015195:Drug Design; D005346:Fibroblast Growth Factors / Q000627:therapeutic use; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000627:therapeutic use; D010446:Peptide Fragments / Q000627:therapeutic use; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D011506:Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy
D047908:Intracellular Signaling Peptides and Proteins; D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010455:Peptides; D011506:Proteins; C414620:fibroblast growth factor 21; C427211:humanin; C102836:parathyroid hormone (1-31)amide, human; D005346:Fibroblast Growth Factors